List of redirects
Jump to navigation
Jump to search
Showing below up to 50 results in range #25,051 to #25,100.
- HL7 → Health Level 7
- HLA → Human leukocyte antigen
- HLA-B7 → HLA-B
- HLA-B8 → HLA-B
- HLA-Cw3 → HLA-C
- HLA DQ → HLA-DQ
- HLA DR → HLA-DR
- HLA DRB1 → HLA-DRB1
- HLA complex → Human leukocyte antigen
- HLA type → Human leukocyte antigen
- HLH → Hemophagocytic lymphohistiocytosis
- HLHS → Hypoplastic left heart syndrome
- HMB-PP → (E)-4-Hydroxy-3-methyl-but-2-enyl pyrophosphate
- HME → Hereditary multiple exostoses
- HMG-CoA lyase deficiency → 3-hydroxy-3-methylglutaryl-CoA lyase deficiency
- HMG-CoA reductase inhibitor → Statin
- HMG-CoA reductase pathway → Mevalonate pathway
- HMG CoA reductase → HMG-CoA reductase
- HMG CoA synthetase deficiency → HMG-CoA synthase
- HMG coenzyme-A reductase inhibitor → Statins
- HMG coenzyme-A reductase inhibitors → Statins
- HMG‑CoA reductase inhibitors → Statins
- HMP shunt → Pentose phosphate pathway
- HMSN → Charcot-Marie-Tooth disease
- HNA → Hereditary neuralgic amyotrophy
- HNF-1 alpha mutated hepatic adenoma → Hepatocellular adenoma
- HNF1-alpha mutated hepatic adenoma → Hepatocellular adenoma
- HNF1-alpha mutated hepatocellular adenoma → Hepatocellular adenoma
- HNPCC → Hereditary nonpolyposis colorectal cancer
- HNPP → Peripheral myelin protein 22
- HOCM → Hypertrophic cardiomyopathy
- HOMO → HOMO/LUMO
- HONK → Hyperosmolar hyperglycemic state
- HOPE-2 → Heart Outcomes Prevention Evaluation
- HOPE-TOO → Heart Outcomes Prevention Evaluation - The Ongoing Outcomes
- HORIZON → Health Outcomes And Reduced Incidence With Zoledronic Once Yearly
- HORIZONS-AMI → Harmonizing Outcomes With Revascularization And Stents In Acute Myocardial Infarction
- HORIZONS-AMI Stent → Harmonizing Outcomes With Revascularization And Stents In Acute Myocardial Infarction
- HOS → Hypertension-Obesity-Sibutramine
- HOS1 → Holt-Oram syndrome
- HOX genes → Homeobox
- HPA axis → Hypothalamic pituitary adrenal axis
- HPD → Histrionic personality disorder
- HPFH → Hereditary persistence of fetal hemoglobin
- HPIV → Human parainfluenza viruses
- HPLC → High performance liquid chromatography
- HPP → Allopurinol
- HPPD → Hallucinogen persisting perception disorder
- HPRT → Hypoxanthine-guanine phosphoribosyltransferase
- HPRT - Hypoxanthine-guanine phosphoribosyltransferase deficiency → Lesch-Nyhan's syndrome